Abstract:The study was to investigate the role of homocysteine (Hcy) which was released by hippocampal glial cells and its relationship with NMDA receptor and AMPA receptor in depression induced by chronic unpredictable mild stress (CUMS), and explore the mechanism of changes of Glu/Glu receptor in glial cells and neurons. CUMS-induced depression model was established. The body weight of rats was weighed on the 1st, 7th, 14th, and 21st days during the experiment. The behavioral performances were observed by means of sucrose consumption test, open field test and tail suspension test. Intrahippocampal microinjection of Hcy, NMDA receptor antagonist MK-801 and AMPA receptor antagonist NBQX was performed under stereotaxic guide cannula. The concentration of Glu and the expression of its receptors' subunits were detected respectively by high performance liquid chromatography (HPLC) and Western blot. The Hcy content and the levels of phosphorylation of NMDA receptor and AMPA receptor in hippocampus were separately determined by enzyme linked immunosorbent assay (ELISA). The results showed that CUMS significantly induced the depression-like behaviors in rats, and the content of Glu and Hcy, the expression of NMDA receptors' subunits NR1/NR2B and the level of phosphorylation of NMDA receptor (p-NMDAR) in hippocampus increased significantly, while the expression of AMPA receptors' subunits GluR2/3 and the level of phosphorylation of AMPA receptor (p-AMPAR) decreased significantly. Microinjection of Hcy into hippocampus resulted in similar animal depression-like behaviors and increased Glu content compared to the CON/SAL group, the expression of NR1/NR2B/GluR2/3 and the level of p-NMDAR increased significantly, but the level of p-AMPAR reduced observably. Intrahippocampal injections of MK-801 effectively improved the depression-like behaviors induced by CUMS and Hcy, and attenuated the elevation of Glu content induced by Hcy in hippocampus, whereas NBQX could not improve the depression-like behaviors, but also decreased the Glu content induced by Hcy remarkably. These results suggest that CUMS may contribute to the production and release of Hcy via hippocampal astrocytes. Through the increase of expression of NR1/NR2B/GluR2/3 and level of p-NMDAR, and the decrease of level of p-AMPAR, Hcy results in elevation of Glu level, which leads to depression-like behaviors in the end. In a word, the Hcy released by astrocytes plays an important role in stress-induced elevation of Glu content and variation of NMDA/AMPA receptors in hippocampus.

Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression

Role of homocysteine in the development of cardiovascular disease

Homocysteine and Hyperhomocysteinaemia

Defective quality control autophagy in Hyperhomocysteinemia promotes ER stress and consequent neuronal apoptosis through proteotoxicity

Homocysteine Thiolactone Detoxifying Enzymes and Alzheimer's Disease

Homocysteine Induces Inflammation in Retina and Brain

The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice

Hyperhomocysteinemia: Metabolic Role and Animal Studies with a Focus on Cognitive Performance and Decline-A Review

Homocysteine, but Not MTHFR Gene Polymorphism, Influences Depressive Symptoms in Patients with Schizophrenia.

Insufficient S-Sulfhydration of Methylenetetrahydrofolate Reductase Contributes to the Progress of Hyperhomocysteinemia.

Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia

The metabolism and significance of homocysteine in nutrition and health

The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art

Disturbed homocysteine metabolism is associated with cancer

[Modulation of Hippocampal Glutamate and NMDA/AMPA Receptor by Homocysteine in Chronic Unpredictable Mild Stress-Induced Rat Depression].

Moderate Elevation of Homocysteine Induces Endothelial Dysfunction through Adaptive UPR Activation and Metabolic Rewiring

Homocysteine Potentiates Copper‐ and Amyloid Beta Peptide‐mediated Toxicity in Primary Neuronal Cultures: Possible Risk Factors in the Alzheimer's‐type Neurodegenerative Pathways

The involvement of hyperhomocysteinemia in the development of characterized depressive disorder in children and adolescents

Homocysteine: A Modifiable Culprit of Cognitive Impairment for Us to Conquer?

Homocysteine impaired endothelial function via compromised VEGF/Akt/eNOS signaling (Revised 1)

Homocysteine, cerebrovascular disease and brain atrophy